295 First-in-human Phase I trial of IBI188, an anti-CD47 targeting monoclonal antibody, in patients with advanced solid tumors and lymphomas
oleh: Hui Zhou, Ying Liu, Fang Liu, Siqing Fu, Nehal Lakhani, Marlana Orloff, Kedan Lin, Shuling Yan
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-11-01 |
Deskripsi
No description available for this item.